Bernhard Hemmerlein

About

Bernhard Hemmerlein has authored 89 papers that have received a total of 3.0k indexed citations. This includes 41 papers in Molecular Biology, 26 papers in Oncology and 21 papers in Cancer Research. The topics of these papers are Peptidase Inhibition and Analysis (8 papers), Renal cell carcinoma treatment (7 papers) and Protease and Inhibitor Mechanisms (6 papers). Bernhard Hemmerlein is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Renal cell carcinoma treatment (7 papers) and Protease and Inhibitor Mechanisms (6 papers) and collaborates with scholars based in Germany, United States and Israel. Bernhard Hemmerlein's co-authors include Paul Thelen, Peter Burfeind, Michal Grzmil, Stefan Schweyer and A. Kugler and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Oncogene.

In The Last Decade

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John G. Raynes Breakdown of academic impact, for papers by Kalevi Salonen Breakdown of academic impact, for papers by Andrea Raffaelli Breakdown of academic impact, for papers by Jean‐Christophe Thalabard Breakdown of academic impact, for papers by V. Himabindu Breakdown of academic impact, for papers by Gerd Bicker Breakdown of academic impact, for papers by Yanbo Li Breakdown of academic impact, for papers by Wei‐June Chen